News
Tuning in from Google's I/O Conference (GOOG, GOOGL) in Mountain View, California, Yahoo Finance tech editor Dan Howley recaps the biggest moments from the first day of the developers conference, ...
Alexia Brue hosts the series. She is the co-founder of award-winning media company, Well+Good, and a longevity entrepreneur, ...
10d
Golf Digest on MSNAmerica's 100 Greatest Golf CoursesGolf Digest has published America’s 100 Greatest Golf Courses since 1966, making it the oldest and most respected ranking in ...
EXCLUSIVE: DC/DOX, the prestigious documentary film festival in the nation's capital, today announced the full slate for its third edition. The cinematic event will include a dozen world premieres ...
It is now illegal to publish or threaten to publish real or AI-generated intimate images of a person without their consent. Tech sites and companies also must take down such images within 48 hours of ...
A big breakthrough is being hailed in the world of gene editing, with the first custom-designed treatment using CRISPR technology . The therapy was developed ...
This valuable study investigates how stochastic and deterministic factors are integrated during cellular decision-making, particularly in situations where cells differentiate into distinct fates ...
A few years ago, a British company called Genus set out to design pigs immune to this germ using CRISPR gene editing. Not only did they succeed, but its pigs are now poised to enter the food chain ...
9d
Pharmaceutical Technology on MSNCan pharma tariffs “Make America Manufacture Again”?Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
One of the all time greatest' Morgan Freeman leads Oscars 'In Memoriam' with Gene Hackman tribute, plus Gena Rowlands, James Earl Jones, and more Katy Perry debunks AI images of her at Met Gala ...
AUSTIN, Texas, May 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...
We see the value of our RSwitch technology as a potential partnering opportunity with companies developing gene and cell therapies to improve the clinical success of these gene replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results